This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

Ciech Valuation

Is CHX undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

5/6

Valuation Score 5/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of CHX when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Discounted Cash Flow
Simply Wall St
€29.51
Fair Value
59.2% undervalued intrinsic discount
2
Number of Analysts

Below Fair Value: CHX (€12.04) is trading below our estimate of fair value (€29.51)

Significantly Below Fair Value: CHX is trading below fair value by more than 20%.


Key Valuation Metric

Which metric is best to use when looking at relative valuation for CHX?

Key metric: As CHX is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.

The above table shows the Price to Earnings ratio for CHX. This is calculated by dividing CHX's market cap by their current earnings.
What is CHX's PE Ratio?
PE Ratio7.6x
Earningszł367.53m
Market Capzł2.79b

Price to Earnings Ratio vs Peers

How does CHX's PE Ratio compare to its peers?

The above table shows the PE ratio for CHX vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PEEstimated GrowthMarket Cap
Peer Average12.8x
SIM0 SIMONA
10.6xn/a€333.0m
FPE3 Fuchs
17.5x8.6%€4.6b
ACT AlzChem Group
12.5x12.8%€626.9m
STO3 Sto SE KGaA
10.5x3.5%€695.3m
CHX Ciech
7.6x4.8%€2.8b

Price-To-Earnings vs Peers: CHX is good value based on its Price-To-Earnings Ratio (7.6x) compared to the peer average (27.2x).


Price to Earnings Ratio vs Industry

How does CHX's PE Ratio compare vs other companies in the European Chemicals Industry?

1 CompanyPrice / EarningsEstimated GrowthMarket Cap
CHX 7.6xIndustry Avg. 18.1xNo. of Companies10PE01224364860+
1 CompanyEstimated GrowthMarket Cap
No more companies

Price-To-Earnings vs Industry: CHX is good value based on its Price-To-Earnings Ratio (7.6x) compared to the European Chemicals industry average (12.7x).


Price to Earnings Ratio vs Fair Ratio

What is CHX's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

CHX PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio7.6x
Fair PE Ratio11.5x

Price-To-Earnings vs Fair Ratio: CHX is good value based on its Price-To-Earnings Ratio (7.6x) compared to the estimated Fair Price-To-Earnings Ratio (11.5x).


Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Analyst Price Target
Consensus Narrative from 2 Analysts
€10.78
Fair Value
11.6% overvalued intrinsic discount
2
Number of Analysts

Analyst Forecast: Insufficient data to show price forecast.


Discover undervalued companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/01/05 04:15
End of Day Share Price 2023/11/15 00:00
Earnings2023/09/30
Annual Earnings2022/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Ciech S.A. is covered by 11 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Kamil KliszczBiuro maklerskie mBanku
Wlodzimierz GillerCitigroup Inc
Lukasz ProkopiukDom Maklerski Banku Ochrony Srodowiska S.A.